Cango (NYSE:CANG) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 73.81 percent increase over losses of $(0.42) per share from the same period last year.
Aspira Women’s Health Announces Transition Of Its Chief Scientific Officer/Chief Operating Officer; Ryan Phan, Ph.D. Stepping Down Effective September 15, 2023
Aspira Women's Health Inc. ("Aspira" or "the Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that Ryan Phan,
